glp-1 alcohol absorption study october 2025 drugs may delay alcohol's effects in the bloodstream GLP-1 Receptor Agonists Protect the
Description
Therapeutic GLP-1 RAs have been engineered to resist degradation by dipeptidyl peptidase-4 (DPP-4), the enzyme responsible for the rapid inactivation of native GLP-1
10.1016/j.molmet.2023.101805 Mol Metab
References Institute of Medicine (US) Subcommittee on Military Weight Management
The novel GLP-1 receptor agonist (Ex-4)2-Fc, developed by Zhou et al., demonstrated anti-inflammatory activity in their study
